Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized Placebo-controlled Parallel Group Study of Probiotics as an Adjuvant Therapy for Individuals With Type 2 Diabetes Mellitus

NCT01752803 is registered in ClinicalTrials.gov with Universiti Kebangsaan Malaysia Medical Centre as lead sponsor.

NCT NCT01752803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01752803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized Placebo-controlled Parallel Group Study of Probiotics as an Adjuvant Therapy for Individuals With Type 2 Diabetes Mellitus
Lead sponsor
Universiti Kebangsaan Malaysia Medical Centre
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2012
Completion date
July 31, 2015
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia, hypertension, obesity, type 2 diabetes mellitus